The addition of LIN28A to DNp53/hTERT/KRAS appears to be a key element permitting in vitro proliferation and in vitro tumor formation in cells with high-level activation of the KRAS/MAP kinase pathway. This evidence concerns the gene KRAS and neoplasm.